Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Seth Klarman, latest 13F

Seth Klarman · Q2 2018

Baupost Group

Portfolio at the end of Q2 2018, from the 13F filed August 13, 2018. See the filing on EDGAR ↗

CompanyWeightValueSharesPriceHeld sinceChange
Twenty-First Century Fox FOXA · history 17.1% $1.96B 39,415,829 $49.69 Q3 2015 Add 48%
Synchrony SYF · history 8.5% $977.9M 29,295,030 $33.38 Q3 2016 No change
Cheniere Energy LNG · history 8.1% $925.4M 14,196,135 $65.19 Q1 2014 Reduce 32%
Viasat VSAT · history 7.9% $902.5M 13,732,068 $65.72 Q2 2013 or earlier Add 1%
Qorvo QRVO · history 7.7% $881.9M 11,000,000 $80.17 Q1 2017 No change
Allergan AGN · history 7.2% $825.3M 4,950,000 $166.72 Q1 2016 Add 4%
Pioneer Natural Resources PXD · history 6.6% $757.0M 4,000,000 $189.24 Q3 2017 No change
Twenty-First Century Fox FOX · history 5.9% $670.4M 13,606,260 $49.27 Q3 2015 Add 19%
Antero Resources AR · history 5.0% $567.6M 26,587,791 $21.35 Q3 2014 No change
DigitalBridge CLNY · history 2.7% $310.0M 49,687,370 $6.24 Q2 2018 Buy
Tesla TSLA.CV · convertible notes · history 2.7% $306.2M 250,000,000 prn Q1 2018 Add 400%
AT&T T · history 2.7% $304.4M 9,480,700 $32.11 Q2 2018 Buy
Cardinal Health CAH · history 2.2% $249.0M 5,100,000 $48.83 Q4 2016 No change
Atara Biotherapeutics ATRA · history 2.0% $229.9M 6,254,632 $36.75 Q4 2014 No change
McKesson MCK · history 1.9% $217.1M 1,627,700 $133.40 Q3 2017 Add 1%
Theravance Biopharma TBPH · history 1.8% $211.1M 9,309,168 $22.68 Q2 2014 No change
PG&E PCG · history 1.7% $191.5M 4,500,000 $42.56 Q1 2018 Add 43%
Cencora COR · history 1.4% $159.8M 1,873,565 $85.27 Q3 2017 Add 42%
Veritiv VRTV · history 1.3% $152.4M 3,824,385 $39.85 Q3 2014 No change
Tribune Media TRCO · history 1.0% $114.7M 2,996,042 $38.27 Q2 2018 Buy
Keryx Biopharmaceuticals KERX · history 0.8% $97.0M 25,791,678 $3.76 Q1 2014 No change
Sinclair SBGI · history 0.7% $82.7M 2,571,302 $32.15 Q2 2018 Buy
AMC Entertainment AMC · history 0.7% $79.5M 5,000,000 $15.90 Q3 2017 No change
Novagold Resources NG · history 0.5% $59.9M 13,467,145 $4.45 Q2 2013 or earlier No change
GTY Technology GTYH.U · units · history 0.4% $45.9M 4,400,000 $10.43 Q4 2016 No change
Theravance Biopharma TBPH.CV · convertible notes · history 0.3% $30.0M 30,000,000 prn Q4 2016 No change
Paratek Pharmaceuticals PRTK · history 0.2% $24.4M 2,394,498 $10.20 Q4 2014 No change
Translate Bio TBIO · history 0.2% $24.3M 1,923,076 $12.65 Q2 2018 Buy
Saban Capital Acquisition SCAC · history 0.2% $23.5M 2,326,500 $10.08 Q4 2016 No change
Trilogy Metals TMQ · history 0.2% $23.2M 13,050,758 $1.77 Q2 2013 or earlier Add 23%
Shire SHPG · history 0.1% $16.7M 98,932 $168.80 Q2 2018 Buy
Sentinel Energy Services STNL.U · units · history 0.1% $16.1M 1,600,000 $10.09 Q4 2017 No change
Saban Capital Acquisition SCAC.WS · warrants · history 0.0% $1.4M 1,163,250 $1.20 Q4 2016 No change
33 positions100.0%$11.44B

Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q1 2018, adjusted for stock splits.

Sector weighting

Sector weights in this 13F
Media & telecom36.0%
Energy19.7%
Health care18.2%
Financials & real estate11.6%
Technology8.1%
Consumer discretionary2.7%
Utilities1.7%
Industrials1.3%
Materials0.7%

What changed from Q1 2018

← Q1 2018 Q3 2018 →